Cargando…
Travel vaccines throughout history
Vaccinations are an important component of travel medicine. Beyond protection of travelers, vaccines are administered to prevent the importation of vaccine-preventable diseases at home and at destination. Proof of immunization to travel dates back to the first smallpox vaccine, developed by Edward J...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837496/ https://www.ncbi.nlm.nih.gov/pubmed/35167951 http://dx.doi.org/10.1016/j.tmaid.2022.102278 |
_version_ | 1784649922366144512 |
---|---|
author | Pavli, Androula Maltezou, Helena C. |
author_facet | Pavli, Androula Maltezou, Helena C. |
author_sort | Pavli, Androula |
collection | PubMed |
description | Vaccinations are an important component of travel medicine. Beyond protection of travelers, vaccines are administered to prevent the importation of vaccine-preventable diseases at home and at destination. Proof of immunization to travel dates back to the first smallpox vaccine, developed by Edward Jenner in 1796. However, it took one century to generate the next vaccines against cholera, rabies, and typhoid fever. During the 20th century the armamentarium of vaccines used in travelers largely expanded with yellow fever, poliomyelitis, tetravalent meningococcal, and hepatitis A vaccines. The International Certificate of Inoculation and Vaccination was implemented in 1933. Currently there are vaccines administered to travelers following risk assessment, but also vaccines required according to the 2005 International Health Regulations and vaccines required at certain countries. Finally, within less than one year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic, the first COVID-19 vaccines were launched and approved for emergency use to control the pandemic. Despite practical and ethical challenges, COVID-19 vaccine verifications have been widely used since spring 2021 in many activities, including international travel. In this article, we review the course of development of travel vaccines focusing on those for which a proof of vaccination has been or is required. |
format | Online Article Text |
id | pubmed-8837496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88374962022-02-14 Travel vaccines throughout history Pavli, Androula Maltezou, Helena C. Travel Med Infect Dis Article Vaccinations are an important component of travel medicine. Beyond protection of travelers, vaccines are administered to prevent the importation of vaccine-preventable diseases at home and at destination. Proof of immunization to travel dates back to the first smallpox vaccine, developed by Edward Jenner in 1796. However, it took one century to generate the next vaccines against cholera, rabies, and typhoid fever. During the 20th century the armamentarium of vaccines used in travelers largely expanded with yellow fever, poliomyelitis, tetravalent meningococcal, and hepatitis A vaccines. The International Certificate of Inoculation and Vaccination was implemented in 1933. Currently there are vaccines administered to travelers following risk assessment, but also vaccines required according to the 2005 International Health Regulations and vaccines required at certain countries. Finally, within less than one year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic, the first COVID-19 vaccines were launched and approved for emergency use to control the pandemic. Despite practical and ethical challenges, COVID-19 vaccine verifications have been widely used since spring 2021 in many activities, including international travel. In this article, we review the course of development of travel vaccines focusing on those for which a proof of vaccination has been or is required. Elsevier Ltd. 2022 2022-02-12 /pmc/articles/PMC8837496/ /pubmed/35167951 http://dx.doi.org/10.1016/j.tmaid.2022.102278 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Pavli, Androula Maltezou, Helena C. Travel vaccines throughout history |
title | Travel vaccines throughout history |
title_full | Travel vaccines throughout history |
title_fullStr | Travel vaccines throughout history |
title_full_unstemmed | Travel vaccines throughout history |
title_short | Travel vaccines throughout history |
title_sort | travel vaccines throughout history |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837496/ https://www.ncbi.nlm.nih.gov/pubmed/35167951 http://dx.doi.org/10.1016/j.tmaid.2022.102278 |
work_keys_str_mv | AT pavliandroula travelvaccinesthroughouthistory AT maltezouhelenac travelvaccinesthroughouthistory |